The experience and research of medical professionals indicate that some long-listed drugs may have efficacy for other than the original indications. As with new medicines, development of such drugs for diseases for which there are currently no particularly effective medications is awaited.
Calvan (Bevantolol hydrochloride)
To discover new uses for our long-listed drugs, we are supporting research in Japan and abroad.In Europe, Spain-based SOM Biotech is developing our Calvan tablets for Huntington’s disease and other conditions. The results of Phase IIb trial was presented at a conference in 2024.
| Business Development We are interested in any opportunities of collaboration, partnering or licensing of our pipeline products and welcome any proposal on them. If you have any interest in any of our pipeline products, please contact our business development team: bd@chemiphar.co.jp. |
NOTICE
To view our PDF files, you need Adobe Reader software installed on your local drive.
The Adobe Reader can be downloaded by clicking on this icon.
